What are the types of coronary artery dominance and their clinical significance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Coronary Artery Dominance: Types and Clinical Significance

Coronary artery dominance is classified into three mutually exclusive categories—right dominant (most common at 80-85%), left dominant (8-10%), and co-dominant (~5%)—determined by which vessel supplies the posterior descending artery (PDA) and posterolateral artery (PLA) to the inferior wall of the left ventricle. 1

Anatomic Definitions

According to the 2014 ACC/AHA standardized definitions 1:

  • Right Dominance: Both the PDA and PLA arise from the right coronary artery (RCA)
  • Left Dominance: Both the PDA and PLA arise from the left circumflex artery (LCx)
  • Co-dominance: The RCA supplies the PDA while the LCx supplies the PLA—both vessels contribute to inferior wall blood supply

The determination is made by identifying which vessel gives rise to the posterior descending artery, typically assessed during coronary angiography or advanced imaging (CTA/MRA). When reporting coronary imaging results, comment should always be made regarding coronary dominance pattern 2.

Clinical Significance and Prognostic Implications

Mortality and Adverse Outcomes

Left coronary dominance carries significantly worse prognosis compared to right dominance, particularly in acute coronary syndromes. The evidence consistently demonstrates:

  • In STEMI patients treated with primary PCI: Left dominance independently predicts mortality (HR 1.76, p=0.02) with 36.4% mortality versus 7.1% in right dominance over 40 months follow-up 3
  • Reinfarction risk: Left dominance independently predicts recurrent MI (subhazard ratio 2.06, p=0.01) 3
  • Periprocedural complications: Left dominance associates with higher periprocedial MI rates (10.3% vs 5.0%, adjusted HR 2.19, p=0.017) following PCI 4

Anatomic and Lesion Characteristics

Patients with left dominance demonstrate distinct anatomic features 5, 4:

  • More severe coronary calcifications (p=0.006)
  • Higher prevalence of bifurcation lesions (p=0.031)
  • Greater overall stenosis burden
  • Target lesions more frequently located in dominant vessels

Conversely, right dominance paradoxically associates with higher total Gensini scores (42.3±33.6 vs 36.3±29.8, p=0.033), suggesting more diffuse disease despite better outcomes 6. This apparent contradiction likely reflects the larger myocardial territory at risk with acute occlusion in left dominant systems.

Diagnostic Considerations

Myocardial Perfusion Imaging Accuracy

Non-right dominant anatomy (left or co-dominant) produces significantly higher false-positive rates on SPECT myocardial perfusion imaging for inferior/inferolateral wall defects 7:

  • False positive rate: 59% in non-right dominant vs 36% in right dominant (p=0.01)
  • Clinical caveat: Exercise caution when interpreting reversible inferior/inferolateral defects in patients with known or suspected non-right dominant anatomy—consider proceeding directly to invasive angiography rather than relying solely on functional imaging

Coronary Functional Testing

When performing invasive coronary functional testing for INOCA/ANOCA evaluation, the left anterior descending (LAD) artery is usually preferred as the target vessel due to its subtended myocardial mass and typical coronary dominance pattern 8. However, test the left circumflex if acetylcholine is administered in the left main coronary artery, and consider additional right coronary testing if initial tests are negative with high clinical suspicion.

Risk Stratification Integration

Including coronary dominance in risk stratification improves discrimination and calibration of established risk scores like GRACE 3. When evaluating patients post-catheterization:

  • Document dominance pattern in all angiography reports
  • Factor left dominance into decisions regarding intensity of secondary prevention
  • Consider more aggressive revascularization strategies in left dominant patients with borderline lesions
  • Maintain heightened surveillance for recurrent events in left dominant patients post-ACS

Common Pitfalls to Avoid

  1. Do not dismiss inferior wall ischemia on stress testing in non-right dominant patients—high false positive rates mean direct angiographic confirmation is often warranted
  2. Do not underestimate procedural risk in left dominant patients—periprocedural MI rates are more than doubled
  3. Do not apply standard risk stratification tools without considering dominance—left dominance independently predicts adverse outcomes beyond traditional risk factors
  4. Do not assume co-dominance is "balanced" and therefore protective—outcomes fall between right and left dominance patterns but still warrant careful attention

The anatomic variation in coronary dominance represents more than descriptive anatomy—it carries meaningful prognostic information that should inform clinical decision-making, procedural planning, and long-term management strategies.

References

4
Research

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015

Related Questions

Which coronary arteries supply each region of the heart wall, including the anterior, anterolateral, lateral, inferior, posterior walls, the interventricular septum, and the atrioventricular node?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
Is porocarcinoma of the thigh classified as a squamous cell carcinoma or as a soft‑tissue sarcoma?
What is the optimal timing for dosing pramipexole to minimize somnolence and avoid stimulation, especially regarding bedtime administration?
Can vildagliptin be used in chronic liver disease, and what dosing and monitoring are recommended for mild‑to‑moderate (Child‑Pugh A/B) versus severe (Child‑Pugh C) hepatic impairment?
What are the contraindications for bone marrow aspiration?
Is a 20 mg dose of valsartan (angiotensin‑II receptor blocker) available or appropriate for treating hypertension?
Does every formulation of amphotericin B need to be diluted in 5% dextrose (D5W)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.